A 15-year-old female adolescent with depression developed myoclonus after u
ninterrupted treatment with sertraline over 6 years. She was also receiving
methylphenidate, Withdrawal of sertraline and continuation of methylphenid
ate did not result in any improvement. Treatment with valproic acid resulte
d in improvement of the movement disorder. This report suggests that myoclo
nus may be a side effect of sertraline in some adolescents. Further, we hyp
othesized that extended treatment over several years, young age, and a comp
romised central nervous system due to underlying disorders may be risk fact
ors for the development of this side effect.